News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,071 Results
Type
Article (87239)
Company Profile (722)
Press Release (770083)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (232975)
Career Advice (4136)
Deals (39782)
Drug Delivery (133)
Drug Development (91204)
Employer Resources (201)
FDA (18247)
Job Trends (17387)
News (397203)
Policy (39898)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (34)
Allergies (118)
Alliances (56979)
ALS (135)
Alzheimer's disease (1643)
Antibody-drug conjugate (ADC) (204)
Approvals (18240)
Artificial intelligence (453)
Autoimmune disease (48)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (435)
Cancer (3528)
Cardiovascular disease (308)
Career advice (3550)
Career pathing (36)
CAR-T (229)
CDC (48)
Cell therapy (627)
Cervical cancer (29)
Clinical research (74921)
Collaboration (1282)
Company closure (4)
Compensation (861)
Complete response letters (50)
COVID-19 (2941)
CRISPR (77)
C-suite (504)
Cystic fibrosis (130)
Data (3753)
Decentralized trials (2)
Denatured (58)
Depression (97)
Diabetes (419)
Diagnostics (7045)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (214)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98636)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132411)
Executive appointments (955)
FDA (20474)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1132)
Gene editing (164)
Generative AI (44)
Gene therapy (495)
GLP-1 (994)
Government (5348)
Grass and pollen (7)
Guidances (333)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (223)
Immuno-oncology (17)
Indications (46)
Infectious disease (3159)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (160)
Interviews (814)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (624)
Leadership (30)
Legal (10144)
Liver cancer (89)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (22)
Management (65)
Manufacturing (563)
MASH (117)
Medical device (14827)
Medtech (14845)
Mergers & acquisitions (22675)
Metabolic disorders (1070)
Multiple sclerosis (117)
NASH (23)
Neurodegenerative disease (183)
Neuropsychiatric disorders (49)
Neuroscience (2534)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (537)
Opinion (303)
Ovarian cancer (114)
Pain (152)
Pancreatic cancer (146)
Parkinson's disease (214)
Partnered (27)
Patents (382)
Patient recruitment (268)
Peanut (56)
People (66057)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23095)
Phase II (32534)
Phase III (24486)
Pipeline (2445)
Policy (279)
Postmarket research (3554)
Preclinical (10429)
Press Release (72)
Prostate cancer (172)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (598)
Real estate (7411)
Recruiting (76)
Regulatory (27684)
Reports (64)
Research institute (2675)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (119)
Series A (186)
Series B (139)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (94)
Tariffs (82)
The Weekly (103)
Vaccines (1010)
Venture capital (63)
Weight loss (372)
Women's health (56)
Worklife (21)
Date
Today (129)
Last 7 days (484)
Last 30 days (2423)
Last 365 days (33882)
2025 (23610)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (295)
Arkansas (14)
Asia (50794)
Australia (8922)
California (8895)
Canada (2698)
China (836)
Colorado (375)
Connecticut (395)
Delaware (239)
Europe (116651)
Florida (1310)
Georgia (303)
Hawaii (3)
Idaho (67)
Illinois (787)
India (45)
Indiana (428)
Iowa (19)
Japan (269)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1215)
Massachusetts (6705)
Michigan (295)
Minnesota (541)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2453)
New Mexico (31)
New York (2420)
North Carolina (1360)
North Dakota (10)
Northern California (3951)
Ohio (280)
Oklahoma (18)
Oregon (49)
Pennsylvania (1854)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3383)
Tennessee (142)
Texas (1390)
United States (33006)
Utah (265)
Virginia (238)
Washington D.C. (82)
Washington State (763)
West Virginia (4)
Wisconsin (91)
There are 858,071 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
September 17, 2025
·
2 min read
Press Releases
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
September 17, 2025
·
3 min read
Press Releases
HHS, CDC Announce First Pharmacist Appointment to ACIP: Hillary F. Blackburn Named Voting Member
September 17, 2025
·
3 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine
September 17, 2025
·
12 min read
Press Releases
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - September 16, 2025
September 17, 2025
·
2 min read
Press Releases
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
September 17, 2025
·
6 min read
Press Releases
Anti-MTBR (microtubule binding region) Tau Antibody Etalanetug Granted FDA Fast Track Designation
September 17, 2025
·
4 min read
FDA
In New DTC Ad Crackdown, FDA Trying to Close a Loophole That Isn’t
While the FDA is trumpeting this new initiative as “sweeping reforms” to the way drug companies can advertise, experts say the regulator is going after a problem that doesn’t exist.
September 17, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
September 17, 2025
·
4 min read
Press Releases
Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business
September 17, 2025
·
2 min read
1 of 85,808
Next
